Potter, JM, Nestel, PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979; 133(2), 165–170.
Desoye, G, Gauster, M, Wadsack, C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011; 94(6 Suppl), 1896S–902S.
Bansal, N, Cruickshank, JK, McElduff, P, Durrington, PN. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol. 2005; 16(4), 400–408.
Misra, VK, Trudeau, S. The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancy. Obesity (Silver Spring). 2011; 19(2), 416–421.
Palinski, W, Yamashita, T, Freigang, S, Napoli, C. Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Reviews. 2007; 65(12 Pt 2), S182–S187.
Edison, RJ, Berg, K, Remaley, A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 2007; 120(4), 723–733.
Leiva, A, Fuenzalida, B, Westermeier, F, et al. Role for tetrahydrobiopterin in the fetoplacental endothelial dysfunction in maternal supraphysiological hypercholesterolemia. Oxid Med Cell Longev. 2015; 2015, 5346327.
Mudd, LM, Holzman, CB, Evans, RW. Maternal mid-pregnancy lipids and birthweight. Acta Obstet Gynecol Scand. 2015; 94(8), 852–860.
Napoli, C, D’Armiento, FP, Mancini, FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100(11), 2680–2690.
Hentschke, MR, Poli-de-Figueiredo, CE, da Costa, BE, Kurlak, LO, Williams, PJ, Mistry, HD. Is the atherosclerotic phenotype of preeclamptic placentas due to altered lipoprotein concentrations and placental lipoprotein receptors? Role of a small-for-gestational-age phenotype. J Lipid Res. 2013; 54(10), 2658–2664.
Wadsack, C, Tabano, S, Maier, A, et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am J Physiol Endocrinol Metab. 2007; 292(2), E476–E484.
Ethier-Chiasson, M, Duchesne, A, Forest, JC, et al. Influence of maternal lipid profile on placental protein expression of LDLr and SR-BI. Biochem Biophys Res Commun. 2007; 359(1), 8–14.
Stefulj, J, Panzenboeck, U, Becker, T, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009; 104(5), 600–608.
Lillycrop, KA, Burdge, GC. Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond). 2011; 35(1), 72–83.
Henikoff, S, Matzke, MA. Exploring and explaining epigenetic effects. Trends Genet. 1997; 13(8), 293–295.
Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16(1), 6–21.
Heijmans, BT, Tobi, EW, Stein, AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008; 105(44), 17046–17049.
Tobi, EW, Lumey, LH, Talens, RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Human Mol Genet. 2009; 18(21), 4046–4053.
Finer, S, Mathews, C, Lowe, R, et al. Maternal gestational diabetes is associated with genome-wide DNA methylation variation in placenta and cord blood of exposed offspring. Human Mol Genet. 2015; 24(11), 3021–3029.
Houde, AA, Guay, SP, Desgagne, V, et al. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics. 2013; 8(12), 1289–1302.
Houde, AA, Ruchat, SM, Allard, C, et al. LRP1B, BRD2 and CACNA1D: new candidate genes in fetal metabolic programming of newborns exposed to maternal hyperglycemia. Epigenomics. 2015; 7(7), 1111–1122.
Ruchat, SM, Houde, AA, Voisin, G, et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics. 2013; 8(9), 935–943.
Houde, AA, St-Pierre, J, Hivert, MF, et al. Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles. J Dev Origins Health Dis. 2014; 5(2), 132–141.
Ahima, RS. Digging deeper into obesity. J Clin Invest. 2011; 121(6), 2076–2079.
Norgan, NG. A review of: “Anthropometric Standardization Reference Manual”. Edited by T. G. LOHMAN, A. F. ROCHE and R. MARTORELL. (Champaign, IL.: Human Kinetics Books, 1988.) [Pp. vi+ 177.] £28·00. ISBN 087322 121 4. Ergonomics. 1988; 31(10), 1493–1494.
Lohman, TG, Roche, AF, Martorell, R. Anthropometric Standardization Reference Manual, 1988. Champaign, IL: Human Kinetics Books.
Friedewald, WT, Levy, RI, Fredrickson, DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6), 499–502.
Fenton, TR, Kim, JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13, 59.
Bouchard, L, Thibault, S, Guay, SP, et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care. 2010; 33(11), 2436–2441.
Cote, S, Gagne-Ouellet, V, Guay, SP, et al. PPARGC1alpha gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns. Clin Epigenet. 2016; 8, 72.
Marsh, S. Pyrosequencing applications. Methods Mol Biol. 2007; 373, 15–24.
Guay, SP, Brisson, D, Lamarche, B, et al. DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability. Atherosclerosis. 2013; 228(2), 413–420.
Guay, SP, Brisson, D, Lamarche, B, Gaudet, D, Bouchard, L. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics. 2014; 9(5), 718–729.
Chatzi, L, Plana, E, Daraki, V, et al. Metabolic syndrome in early pregnancy and risk of preterm birth. American J Epidemiol. 2009; 170(7), 829–836.
Clausen, T, Burski, TK, Oyen, N, Godang, K, Bollerslev, J, Henriksen, T. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol. 2005; 153(6), 887–894.
Ramsay, JE, Ferrell, WR, Crawford, L, Wallace, AM, Greer, IA, Sattar, N. Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens. 2004; 22(11). 2177–2183.
Tyrrell, J, Richmond, RC, Palmer, TM, et al. Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA. 2016; 315(11), 1129–1140.
Clausen, TD, Mathiesen, ER, Hansen, T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009; 94(7), 2464–2470.
Van der Graaf, A, Vissers, MN, Gaudet, D, et al. Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adults offspring. Arteriosclerosis Thromb Vasc Biol. 2010; 30(12), 2673–2677.
Sitras, V, Fenton, C, Paulssen, R, Vartun, A, Acharya, G. Differences in gene expression between first and third trimester human placenta: a microarray study. PLoS One. 2012; 7(3), e33294.
Rakyan, VK, Down, TA, Balding, DJ, Beck, S. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011; 12(8), 529–541.
Toperoff, G, Aran, D, Kark, JD, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Human Mol Genet. 2012; 21(2), 371–383.
Stepan, H, Faber, R, Walther, T. Expression of low density lipoprotein receptor messenger ribonucleic acid in placentas from pregnancies with intrauterine growth retardation. Br J Obstet Gynaecol. 1999; 106(11), 1221–1222.
Frantz, E, Menezes, HS, Lange, KC, et al. The effect of maternal hypercholesterolemia on the placenta and fetal arteries in rabbits. Acta Cir Bras. 2012; 27(1), 7–12.
Hussain, MM, Strickland, DK, Bakillah, A. The mammalian low-density lipoprotein receptor family. Annu Rev Nutr. 1999; 19, 141–172.
May, P, Rohlmann, A, Bock, HH, et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol. 2004; 24(20), 8872–8883.
Liu, Q, Zhang, J, Zerbinatti, C, et al. Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol. 2011; 9(1), e1000575.
Hofmann, SM, Zhou, L, Perez-Tilve, D, et al. Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice. J Clin Invest. 2007; 117(11), 3271–3282.
Cardenas, A, Koestler, DC, Houseman, EA, et al. Differential DNA methylation in umbilical cord blood of infants exposed to mercury and arsenic in utero. Epigenetics. 2015; 10(6), 508–515.
Banik, A, Kandilya, D, Ramya, S, Stunkel, W, Chong, YS, Dheen, ST. Maternal factors that induced epigenetic changes contribute to neurological disorders in offspring. Genes. 2017; 8(6), E150.